Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill children
暂无分享,去创建一个
D. Teachey | Jose S. Campos | E. Wherry | Peyton E. Conrey | Steven M Holland | Deanne M. Taylor | Nuala J. Meyer | Scott L. Weiss | Samir Sayed | Jennifer W Leiding | Robert B. Lindell | Montana Knight | Andrea A Mauracher | Ceire A. Hay | Julie C. Fitzgerald | Nadir Yehya | S. Famularo | Teresa Arroyo | Richard Tustin | Hossein Fazelinia | Edward M. Behrens | Alexandra F. Freeman | Jenna R. E. Bergerson | Mark W. Hall | A.F. Zuppa | Rui Feng | S. E. Henrickson | J. C. Fitzgerald | Edward M Behrens
[1] T. Sweeney,et al. Monocyte state 1 (MS1) cells in critically ill patients with sepsis or non-infectious conditions: association with disease course and host response , 2024, Critical care.
[2] Nuala J Meyer,et al. Charting a course for precision therapy trials in sepsis. , 2024, The Lancet. Respiratory medicine.
[3] R. Lodha,et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock. , 2024, JAMA.
[4] M. Churpek,et al. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. , 2023, The Lancet. Respiratory medicine.
[5] J. Todd,et al. Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis , 2023, Nature Immunology.
[6] N. Meyer,et al. Interrogating the sepsis host immune response using cytomics , 2023, Critical Care.
[7] E. Wherry,et al. Impaired Lymphocyte Responses in Pediatric Sepsis Vary by Pathogen Type and are Associated with Features of Immunometabolic Dysregulation , 2022, Shock.
[8] M. Singer,et al. Redefining critical illness , 2022, Nature Medicine.
[9] J. Casanova,et al. Diagnosis of APS-1 in Two Siblings Following Life-Threatening COVID-19 Pneumonia , 2022, Journal of Clinical Immunology.
[10] J. Soar,et al. An immune dysfunction score for stratification of patients with acute infection based on whole blood gene expression , 2022, Science Translational Medicine.
[11] K. C. Morris,et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis , 2022, medRxiv.
[12] Paul J. Hoffman,et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis , 2022, bioRxiv.
[13] S. de Bono,et al. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial , 2022, The Lancet Respiratory Medicine.
[14] J. Casanova,et al. Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome , 2022, Journal of Clinical Immunology.
[15] J. Carcillo,et al. Scoring Systems for Organ Dysfunction and Multiple Organ Dysfunction: The PODIUM Consensus Conference. , 2022, Pediatrics.
[16] M. Spaeder,et al. Patterns of Organ Dysfunction in Critically Ill Children Based on PODIUM Criteria. , 2022, Pediatrics.
[17] J. Carcillo,et al. Refining the Pediatric Multiple Organ Dysfunction Syndrome. , 2022, Pediatrics.
[18] D. Teachey,et al. Temperature Trajectory Sub-phenotypes and the Immuno-Inflammatory Response in Pediatric Sepsis , 2021, Shock.
[19] Xiaoying Hu,et al. The JAK/STAT signaling pathway: from bench to clinic , 2021, Signal Transduction and Targeted Therapy.
[20] A. Hingorani,et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling , 2021, Nature Communications.
[21] I. Grundberg,et al. Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis , 2021, Molecular & cellular proteomics : MCP.
[22] E. Wherry,et al. Impaired Lymphocyte Responses in Pediatric Sepsis Vary by Pathogen Type , 2021, medRxiv.
[23] Brenda J. Crowe,et al. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial , 2021, The Lancet Respiratory Medicine.
[24] D. Quirk,et al. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia , 2021, The New England journal of medicine.
[25] P. Khatri,et al. Gene Expression–Based Diagnosis of Infections in Critically Ill Patients—Prospective Validation of the SepsisMetaScore in a Longitudinal Severe Trauma Cohort , 2021, Critical care medicine.
[26] Santiago J. Carmona,et al. UCell: Robust and scalable single-cell gene signature scoring , 2021, bioRxiv.
[27] John C. Lin,et al. Prevalence of Pathogenic and Potentially Pathogenic Inborn Error of Immunity Associated Variants in Children with Severe Sepsis , 2021, Journal of clinical immunology.
[28] Ariel J. Levine,et al. Confronting false discoveries in single-cell differential expression , 2021, Nature Communications.
[29] Yutaka Suzuki,et al. Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens , 2021, Scientific reports.
[30] Cameron R. Wolfe,et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 , 2020, The New England journal of medicine.
[31] J. Knight,et al. Host genetics and infectious disease: new tools, insights and translational opportunities , 2020, Nature Reviews Genetics.
[32] D. Figarella-Branger,et al. SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution. , 2020, Cell metabolism.
[33] N. Matsuda,et al. Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis , 2020, Scientific Reports.
[34] Douglas R. McDonald,et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1 , 2020, Journal of Allergy and Clinical Immunology.
[35] J. Schuurs-Hoeijmakers,et al. Presence of Genetic Variants Among Young Men With Severe COVID-19. , 2020, JAMA.
[36] Yufeng Hu,et al. Phospho-Tyr705 of STAT3 is a therapeutic target for sepsis through regulating inflammation and coagulation , 2020, Cell Communication and Signaling.
[37] F. Meziani,et al. JAK-STAT Targeting Offers Novel Therapeutic Opportunities in Sepsis. , 2020, Trends in molecular medicine.
[38] E. Latz,et al. STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression , 2020, Nature Communications.
[39] Ranjit S. Chima,et al. Trajectories and Risk Factors for Altered Physical and Psychosocial Health-Related Quality of Life After Pediatric Community-Acquired Septic Shock* , 2020, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[40] A. Nishisaki,et al. Risk of Mortality in Immunocompromised Children With Severe Sepsis and Septic Shock , 2020, Critical care medicine.
[41] Amber Dance. What is a cytokine storm? , 2020 .
[42] L. Coin,et al. Whole-exome Sequencing for the Identification of Rare Variants in Primary Immunodeficiency Genes in Children With Sepsis: A Prospective, Population-based Cohort Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] Ranjit S. Chima,et al. Critical Illness Factors Associated With Long-Term Mortality and Health-Related Quality of Life Morbidity Following Community-Acquired Pediatric Septic Shock* , 2020, Critical care medicine.
[44] C. Deutschman,et al. MITOCHONDRIAL DYSFUNCTION IS ASSOCIATED WITH AN IMMUNE PARALYSIS PHENOTYPE IN PEDIATRIC SEPSIS. , 2019, Shock.
[45] C. Lindsell,et al. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model , 2019, Science Translational Medicine.
[46] C. Deutschman,et al. Persistent Mitochondrial Dysfunction Linked to Prolonged Organ Dysfunction in Pediatric Sepsis. , 2019, Critical care medicine.
[47] E. K. Shriver,et al. A Multicenter Network Assessment of Three Inflammation Phenotypes in Pediatric Sepsis-Induced Multiple Organ Failure. , 2019, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[48] J. Casanova,et al. Severe influenza pneumonitis in children with inherited TLR3 deficiency , 2019, The Journal of experimental medicine.
[49] Jeremy C. Weiss,et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. , 2019, JAMA.
[50] Leland McInnes,et al. UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..
[51] S. Elledge,et al. Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency , 2018, The Journal of experimental medicine.
[52] Michael Barnes,et al. M3C: Monte Carlo reference-based consensus clustering , 2018, Scientific Reports.
[53] Purvesh Khatri,et al. Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters , 2018, Critical care medicine.
[54] Purvesh Khatri,et al. A community approach to mortality prediction in sepsis via gene expression analysis , 2018, Nature Communications.
[55] Peter Nürnberg,et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.
[56] V. Nadkarni,et al. The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die* , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[57] Paul J. Rathouz,et al. Regularized Ordinal Regression and the ordinalNet R Package , 2017, J. Stat. Softw..
[58] P. Jouvet,et al. Modalities and Complications Associated With the Use of High-Flow Nasal Cannula: Experience in a Pediatric ICU , 2016, Respiratory Care.
[59] J. Fellay,et al. Exome Sequencing Reveals Primary Immunodeficiencies in Children with Community-Acquired Pseudomonas aeruginosa Sepsis , 2016, Front. Immunol..
[60] Hao Chen,et al. Cytofkit: A Bioconductor Package for an Integrated Mass Cytometry Data Analysis Pipeline , 2016, PLoS Comput. Biol..
[61] Hao Chen,et al. flowAI: automatic and interactive anomaly discerning tools for flow cytometry data , 2016, Bioinform..
[62] J. Knight,et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study , 2016, The Lancet. Respiratory medicine.
[63] J. Casanova. Severe infectious diseases of childhood as monogenic inborn errors of immunity , 2015, Proceedings of the National Academy of Sciences.
[64] Y. Saeys,et al. FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[65] Purvesh Khatri,et al. A comprehensive time-course–based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set , 2015, Science Translational Medicine.
[66] D. Chaussabel,et al. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency , 2015, Science.
[67] C. Lindsell,et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. , 2015, American journal of respiratory and critical care medicine.
[68] V. Nadkarni,et al. Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells in Pediatric Septic Shock* , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[69] G. Besner,et al. Innate Immune Function Predicts the Development of Nosocomial Infection in Critically Injured Children , 2014, Shock.
[70] M. Hall,et al. Early adaptive immune suppression in children with septic shock: a prospective observational study , 2014, Critical Care.
[71] J. Marshall,et al. Why have clinical trials in sepsis failed? , 2014, Trends in molecular medicine.
[72] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[73] Bruno Grandbastien,et al. PELOD-2: An Update of the PEdiatric Logistic Organ Dysfunction Score , 2013, Critical care medicine.
[74] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[75] A. Randolph,et al. Innate Immune Function and Mortality in Critically Ill Children With Influenza: A Multicenter Study* , 2013, Critical care medicine.
[76] E. Steyerberg,et al. Extending the c‐statistic to nominal polytomous outcomes: the Polytomous Discrimination Index , 2012, Statistics in medicine.
[77] J. Carcillo,et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome , 2011, Intensive Care Medicine.
[78] H. Wong,et al. Leukocyte subset-derived genomewide expression profiles in pediatric septic shock* , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[79] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[80] P. Fawcett,et al. Function of Mitochondrial Stat3 in Cellular Respiration , 2009, Science.
[81] J. Ritz,et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. , 2006, Blood.
[82] H. Zou,et al. Addendum: Regularization and variable selection via the elastic net , 2005 .
[83] J. Mesirov,et al. From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .
[84] S. Sebti,et al. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. , 2005, Cancer research.
[85] A. Randolph,et al. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[86] Alain Martinot,et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study , 2003, The Lancet.
[87] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[88] J. Carcillo,et al. Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[89] John C. Lin,et al. New or Progressive Multiple Organ Dysfunction Syndrome in Pediatric Severe Sepsis: A Sepsis Phenotype With Higher Morbidity and Mortality. , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[90] J. Mesirov,et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.
[91] J. Zimmerman,et al. Pediatric Multiple Organ Dysfunction Syndrome , 2006 .
[92] M. Mathru. Accelerated Lymphocyte Death in Sepsis Occurs by Both the Death Receptor and Mitochondrial PathwaysHotchkiss RS, Osmon SB, Chang KC, et al (Washington Univ, St Louis) J Immunol 174:5110–5118, 2005§ , 2006 .
[93] Hua Yu,et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.